Nichols Weston 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 25, 2019
Insider Transaction Report
Form 4
Nichols Weston
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-21+12,500→ 12,500 totalExercise: $23.24Exp: 2029-06-20→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.